Publication
Nanotechnology and antioxidant therapy: An emerging approach for neurodegenerative diseases
| dc.contributor.author | Fernandes, Carlos | |
| dc.contributor.author | Oliveira, Catarina | |
| dc.contributor.author | Benfeito, Sofia | |
| dc.contributor.author | Soares, Pedro | |
| dc.contributor.author | Garrido, Jorge | |
| dc.contributor.author | Borges, Fernanda | |
| dc.date.accessioned | 2015-01-19T14:32:14Z | |
| dc.date.available | 2015-01-19T14:32:14Z | |
| dc.date.issued | 2014-12 | |
| dc.description.abstract | The efficacy, cellular uptake and specific transport of dietary antioxidants to target organs, tissues and cells remains the most important setback for their application in the treatment of oxidative-stress related disorders and in particular in neurodegenerative diseases, as brain targeting remains a still unsolved challenge. Nanotechnology based delivery systems can be a solution for the above mentioned problems, specifically in the case of targeting dietary antioxidants with neuroprotective activity. Nanotechnology-based delivery systems can protect antioxidants from degradation, improve their physicochemical drug-like properties and in turn their bioavailability. The impact of nanomedicine in the improvement of the performance of dietary antioxidants, as protective agents in oxidative- stress events, specifically through the use of drug delivery systems, is highlighted in this review as well as the type of nanomaterials regularly used for drug delivery purposes. From the data one can conclude that the research combining (dietary) antioxidants and nanotechnology, namely as a therapeutic solution for neurodegenerative diseases, is still in a very early stage. So, a huge research area remains to be explored that hopefully will yield new and effective neuroprotective therapeutic agents in a foreseeable future. | por |
| dc.description.sponsorship | This project was supported by the Foundation for Science and Technology (FCT), Portugal (PEst-C/QUI/UI0081/2013 and QREN (FCUP-CIQ-UP-NORTE-07-0124-FEDER- 000065). FCT grants of Carlos Fernandes (SFRH/BD/98519/2013), Catarina Oliveira (SFRH/BD/88773/2012) and Sofia Benfeito (SFRH/BD/99189/2013) are also acknowledged. | por |
| dc.identifier.doi | 10.2174/0929867321666140915141836 | |
| dc.identifier.uri | http://hdl.handle.net/10400.22/5440 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Bentham | por |
| dc.relation.ispartofseries | Current Medicinal Chemistry;Vol. 21, issue 38 | |
| dc.relation.publisherversion | http://benthamscience.com/journal/abstracts.php?journalID=cmc&articleID=124595 | por |
| dc.subject | Dietary antioxidants | por |
| dc.subject | Nanocarriers | por |
| dc.subject | Neurodegenerative diseases | por |
| dc.subject | Oxidative-stress related diseases | por |
| dc.title | Nanotechnology and antioxidant therapy: An emerging approach for neurodegenerative diseases | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 4327 | por |
| oaire.citation.issue | 38 | por |
| oaire.citation.startPage | 4311 | por |
| oaire.citation.volume | 21 | por |
| person.familyName | Garrido | |
| person.givenName | Jorge | |
| person.identifier.orcid | 0000-0001-8981-231X | |
| person.identifier.scopus-author-id | 7202779733 | |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | article | por |
| relation.isAuthorOfPublication | f548e711-c68e-4c49-9471-9923c047116d | |
| relation.isAuthorOfPublication.latestForDiscovery | f548e711-c68e-4c49-9471-9923c047116d |